Search results for: 'plan 1'

This edition of the Life Science, Health & Wellness Technology Opportunity Engine (TOE) provides a comprehensive overview of breakthrough innovations reshaping therapeutics, diagnostics, and drug delivery across infectious diseases, oncology, rare genetic disorders, autoimmune conditions, cardiovascular disease, pulmonary fibrosis, neurodegeneratio...

This edition of the Life Science, Health & Wellness Technology Opportunity Engine (TOE) provide insights across new biologics, and precision cancer therapy innovations. The research also comprises small molecule, cell and gene therapy and gene editing advancements for Niemann–Pick Disease and autoimmune diseases.The Life Science, Health & Wellness ...

This edition of the Life Science, Health & Wellness Technology Opportunity Engine (TOE) highlights recent advances in targeted therapies for cancer, immunological and inflammatory diseases. The research also covers technological developments across vaccines, neuroprotective medicines, cell therapies, monoclonal antibody and oncolytic virus platform...

The report explores the transformation of obesity care from generalized BMI-based treatment to AI-enabled precision metabolic management. The study highlights how obesity is increasingly recognized as a heterogeneous, multi-pathway disease influenced by genetic, neurobehavioral, metabolic, and environmental factors, requiring personalized therapeut...

The latest issue of Advanced MedTech Technology Opportunity Engine (TOE) profiles a wide range of innovations from the advanced medical devices, immersive technologies, and diagnostics industry. The issue includes advanced medical devices such as implant to treat severe emphysema, platform for developing 3D models for surgical planning, point-of-ca...

This edition of the Life Science, Health & Wellness Technology Opportunity Engine (TOE) encompasses insights across advances in targeted neurological therapies, cancer treatments, and AI-powered drug development. The TOE also features innovators for treatment of metabolic diseases such as obesity and heart failure.The Life Science, Health & Wellnes...

The SCOPE Summit 2026, held in Orlando, Florida, from February 2 to 5, 2026, highlighted the dominance of small- to mid-segment companies and specialized CROs focusing on specific therapy areas or aspects of clinical trials, such as bioanalysis. With more than 4,000 attendees, 630 speakers, and 300 exhibitors, SCOPE 2026 reinforced its position as ...

The latest issue of Advanced MedTech Technology Opportunity Engine (TOE) profiles a wide range of innovations from the advanced medical devices, medical imaging, digital health and diagnostics industry. The issue includes advanced medical devices such as surgical robot, teleoperated robotic surgical system, autonomous navigation robot, endoscopic b...

This edition of the Life Science, Health & Wellness Technology Opportunity Engine (TOE) highlights recent advances in biological therapies such as RNA therapies, biosimilars, gene therapies and cell therapies for the management of diseases such as cancer, neurodegenerative disorders and rare diseases. The research also provides technological insigh...